作为脊椎关节炎和牛皮炎炎症的驱动因素的Treg细胞可塑性
Ingrid Itzayanna Ortega-Mejia1,2, Nayeli Romero-López1,2, Julio César Casasola-Vargas3
1Laboratorio de Patogénesis Molecular, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla de Baz, Estado de Mexico, Mexico.
Frontiers in immunology
|August 8, 2025
概括
调节性T细胞 (Tregs) 在慢性炎症性疾病 (如脊髓关节炎和牛皮) 中失去稳定性. 这种Treg可塑性有助于疾病的进展,对有效的治疗策略构成挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 炎症研究 炎症研究
背景情况:
- 调节性T细胞 (Tregs) 对免疫耐受性至关重要.
- 在脊椎关节炎 (SpA) 和牛皮 (PsO) 中,Tregs可以变得不稳定和促炎症.
- 这种Treg可塑性有助于慢性炎症疾病的发病.
研究的目的:
- 研究Treg可塑性在SpA和PsO中的机制.
- 了解Tregs在炎症条件下如何获得致病特征.
- 探索Treg不稳定性对疾病治疗的影响.
主要方法:
- 在SPA和PSO患者样本中分析Treg功能和数量.
- 研究参与Treg重编程的细胞因子信号通路 (例如,STAT3,ICOS).
- 单细胞转录组分析以研究Treg和效应T细胞相互作用.
- 对影响Treg稳定性的环境因素 (如低氧) 的检查.
主要成果:
- 在SpA和PsO中的Tregs降低FoxP3,上调RORγt,并产生促炎性细胞因子 (IL-17,IFN-γ).
- 特定的Treg子集 (例如CD161+Tregs) 呈现出类似于Th17的特征.
- 遗传因素 (例如,HLA-B27) 和炎症信号促进Treg的不稳定性.
- 在Tregs和效应T细胞之间共享的TCR剧目表明了血统可塑性.
- 环境因素,如缺氧进一步破坏Treg身份的稳定性.
结论:
- 特雷格可塑性是SpA和PsO进展的重要因素.
- 致病性Tregs即使在向治疗后仍然存在,这表明治疗挑战.
- 了解Treg可塑性对于开发更有效的慢性炎症疾病治疗方法至关重要.
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Inflammatory Response
7.3K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.3K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
233
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
233
Autoimmune Disorders
676
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
676


